Oscar Health (OSCR) rockets 22% on narrower Q4 loss and impressive 2024 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Oscar Health Inc. (OSCR) Tops Q4 EPS by 6c; offers guidance
February 7, 2024 4:29 PM ESTOscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.66), $0.06 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.43 billion.
GUIDANCE:
Oscar Health Inc. sees FY2024 revenue of $8.3-8.4 billion, versus the... More
